In reply: Cheong notes that the terms “sensitivity” and “specificity” have a slightly different meaning in our study compared with the usual definitions. This was intentional, and the definitions we used are clearly described in our article.1
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1 Pharmaceutical Decision Support Program, National Prescribing Service, Melbourne, VIC.
- 2 University of Sydney, Sydney, NSW.
- 3 University of New South Wales, Sydney, NSW.
- 4 Belgravia Medical Centre, Perth, WA.
- 5 Departments of Internal Medicine and Chemical Pathology, Royal Brisbane and Women’s Hospital, Brisbane, QLD.
- 6 Diamantina Institute, University of Queensland, Brisbane, QLD.
- 7 Austin Health, Melbourne, VIC.
Correspondence: msweidan@nps.org.au
- 1. Sweidan M, Reeve JF, Brien JE, et al. Quality of drug interaction alerts in prescribing and dispensing software. Med J Aust 2009; 190: 251-254. <MJA full text>
- 2. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003) 2004; 44: 136-141.
- 3. Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 2007; 63: 709-714.
Online responses are no longer available. Please refer to our instructions for authors page for more information.